TrialMedical oncology (Northwood, London, England)2015

A phase II clinical study of using nab-paclitaxel as second-line chemotherapy for Chinese patients with advanced non-small cell lung cancer.

Wei Hu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.